Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT03158883 2021-10-20

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

Phase EARLY_PHASE1 Completed

8 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02222922 2020-12-17

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Phase 1 Completed

138 enrolled 98 charts

BreastGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT02395172 2020-08-03

Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

Phase 3 Completed

792 enrolled 26 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

PAVE-1

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

CLASSICAL-Lung

PINNACLE

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)